http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35823491
Outgoing Links
Predicate
Object
contentType
Journal Article|Review
issn
2059-3635
issueIdentifier
1
pageRange
248-
publicationName
Signal Transduction and Targeted Therapy
startingPage
248
hasFundingAgency
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_697eaf060664b536cda00cecce78b9d5
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation
Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future. Signal Transduct Target Ther. 2023 Jun 30;8(1):248. PMID: 37386015; PMCID: PMC10310781.
creator
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7661fa5207d4a35ea3efe28a68168654
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f70cc1b04c649896960b62801fd9b17
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9928-889X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ecb882667be6d9b898413bef87cfe02a
date
2023-06-30-04:00
^^<
http://www.w3.org/2001/XMLSchema#date
>
identifier
https://pubmed.ncbi.nlm.nih.gov/PMC10310781
https://doi.org/10.1038/s41392-023-01484-7
https://pubmed.ncbi.nlm.nih.gov/37386015
isPartOf
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/44885
https://portal.issn.org/resource/ISSN/2059-3635
language
English
source
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title
Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future
discusses
http://id.nlm.nih.gov/mesh/M0024786
discussesAsDerivedByTextMining
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11262
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852
Total number of triples:
27
.